Rescearch On The M&A Performance Of Medical Enterprises

With the advent of the 40th of reform and opening up,the competition environment in China's anniversary medical field is becoming increasingly fierce.If medical enterprises want to achieve better development in the fierce market environment,it is difficult for them to rely on their own profits.In this case,merger and acquisition provides a new way for the survival of pharmaceutical enterprises.We are delighted to see that China's medical industry is undergoing profound changes.Factors such as the reform of medical insurance payment,the reform of drug procurement mode,the reform of tax system and the tightening of environmental supervision have brought certain transformation pressure to the manufacturing enterprises.Policies such as zero tariff on imported cancer drugs,the new version of essential drugs catalog and the green channel policy for innovative drugs have further promoted the industrial upgrading.At present,the expansion of a-share merger and acquisition has become an irresistible trend,so it is of great significance to study the performance of merger and acquisition of medical enterprises in the future.The research idea of this paper is as follows:firstly,this paper studies the influence of m&a on enterprises and the evaluation of m&a performance,and sorts out relevant domestic and foreign literatures.Secondly,from the perspective of corporate mergers and acquisitions,combined with the research of domestic and foreign scholars,analyze the reasons for corporate mergers and acquisitions.Then,in order to better evaluate the post-merger performance of the enterprise,through consulting and sorting out the literature,it is determined that the case in this paper mainly USES the event study method,financial index method and data envelopment analysis(DEA)method to measure the post-merger performance of the enterprise Then,through the analysis of the development of China's medical industry and the status quo of mergers and acquisitions,it is found that China's medical industry in recent years,mergers and acquisitions of high enthusiasm and many events.Then,through the accounting of the performance level of yuyue medical,a representative enterprise in the medical industry,Suggestions and countermeasures are proposed to improve the performance level of mergers and acquisitions in the medical industryThrough the analysis and evaluation of the cases of diving medical treatment,this paper,as diving medical treatment,comes to the following Suggestions:optimize the industrial structure,strengthen its own brand construction;Increase technological innovation and enhance their own strength;Strengthen the whole and digestion after merger and acquisition,improve the efficiency of resource utilization.This case extends to the whole industry,and it is believed that:first,scientific control of merger and acquisition risk,in order to achieve the purpose of improving the performance of enterprise merger and acquisition.Second,enhance the pertinence of enterprise merger and acquisition,and further improve the core competitiveness of enterprises Third,focus on medical service innovation into the grassroots,make full use of quality medical resources.Fourth,we will increase input in drug research and development to achieve new breakthroughs in technology...